AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical PLEASANTON, Calif., May 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its keynote speakers for the 2025 Veeva Commercial Summit, May 13-14 in Boston. Leading and emerging biopharmas will share innovations and strategies to drive more coordinated customer engagement through effective use of AI and alignment across data, content, and teams.Veeva Systems (PRNewsfoto/Veeva Systems) Veeva CEO Peter Gassner will headline the opening keynote, sharing Veeva's major initiative to add AI to the Vault Platform and Veeva applications, including ongoing innovations across Veeva Commercial Cloud and Veeva Data Cloud. Keynote presenters will include experiences from: AstraZeneca standardizing analytics across its brands to boost marketing reach and performance. Bayer driving customer-centric, coordinated engagement with Vault CRM. Boehringer Ingelheim connecting scientific insights across medical to drive effective, personalized key opinion leader conversations. Lilly integrating its content ecosystem by streamlining workflows, standardizing taxonomy, and aligning global teams to deliver high-impact experiences at scale. Johnson & Johnson and Madrigal each building a modern data foundation with connected insights for greater efficiency and field impact. ANI Pharmaceuticals, Gamida Cell, NewAmsterdam Pharma, Orchard Therapeutics, Sobi, and others will also share go-to-market best practices for emerging biotechs at launch and beyond. "By connecting sales, marketing, and medical, field teams can seamlessly work together to drive more effective, customer-centric experiences," said Matt Farrell, president of Veeva Commercial Cloud. "We're excited to bring the industry together to share ideas and advancements in AI and data and help lead this next phase of unified engagement." Veeva Commercial Summit is one of the largest industry events in North America for commercial and medical affairs leaders. Life sciences industry professionals can register and see the full agenda at veeva.com/Summit. About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com. Story Continues Veeva Forward-looking Statements This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at sec.gov. Contact: Matilde Macieira-Kaufmann Veeva Systems 925-226-8821 [email protected] View original content to download multimedia:https://www.prnewswire.com/news-releases/life-sciences-leaders-advance-unified-engagement-at-veeva-commercial-summit-302446874.html SOURCE Veeva Systems View Comments
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...